CSLLY Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 Mai 2024 @ 21:57):

Stats
Tagesvolumen	50 646.00
Durchschnittsvolumen	34 347.00
Marktkapitalisierung	86.15B
Last Dividend	$0.645 ( 2023-09-08 )
Next Dividend	$0 ( N/A )
P/E	35.09
ATR14	$0.603 (0.68%)

Volumen Korrelation

Lang: 0.08 (neutral)

Kurz: 0.81 (strong)

Signal:(47.236) Same movement expected

CSL Limited Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

CSL Limited Korrelation - Währung/Rohstoff

0.44
( neutral )

0.47
( neutral )

0.43
( neutral )

0.35
( neutral )

-0.19
( neutral )

CSL Limited Finanzdaten

Annual	2023
Umsatz:	$13.17B
Bruttogewinn:	$6.71B (50.92 %)
EPS:	$2.27

FY	2023
Umsatz:	$13.17B
Bruttogewinn:	$6.71B (50.92 %)
EPS:	$2.27

FY	2022
Umsatz:	$10.49B
Bruttogewinn:	$5.66B (53.97 %)
EPS:	$2.40

FY	2021
Umsatz:	$10.27B
Bruttogewinn:	$5.80B (56.49 %)
EPS:	$2.62

Financial Reports:

No articles found.

CSL Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.590 (N/A)	$0 (N/A)	$0.535 (N/A)	$0 (N/A)	$0.645 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

CSL Limited Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 6.59 - Stable (31.80%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.158	2010-03-10
Last Dividend	$0.645	2023-09-08
Next Dividend	$0	N/A
Payout Date	2023-09-09
Next Payout Date	N/A
# dividends	28	--
Total Paid Out	$10.42	--
Avg. Dividend % Per Year	0.00%	--
Score	4.16	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	6.59
Div. Directional Score	9.59	--

Next Divdend (Est)
(2024-07-01)

$0.671 Estimate 7.55 %

Dividend Stability

0.30 Poor

Dividend Score

4.16

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PFLC	Ex Dividend Knight	2023-08-10	Quarterly	0.00%
DWAHF	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
UEPEM	Ex Dividend Knight	2023-07-20	Quarterly	0.00%
JSCPF	Ex Dividend Junior	2023-09-28	Annually	0.00%
BORT	Ex Dividend Junior	2023-08-10	Quarterly	0.00%
RSTRF	Ex Dividend Knight	2023-09-19	Semi-Annually	0.00%
FETM	Ex Dividend Knight	2023-08-04	Quarterly	0.00%
WLWHY	Ex Dividend Junior	2023-09-21	Annually	0.00%
LYBC	Ex Dividend Knight	2023-09-28	Quarterly	0.00%
CKHGY	Ex Dividend Knight	2023-05-11	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.177	1.500	6.45	9.68	[0 - 0.5]
returnOnAssetsTTM	0.118	1.200	6.06	7.27	[0 - 0.3]
returnOnEquityTTM	0.212	1.500	8.76	10.00	[0.1 - 1]
payoutRatioTTM	0.258	-1.000	7.42	-7.42	[0 - 1]
currentRatioTTM	2.15	0.800	4.25	3.40	[1 - 3]
quickRatioTTM	0.971	0.800	9.00	7.20	[0.8 - 2.5]
cashRatioTTM	0.216	1.500	9.91	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.30	-7.95	[0 - 0.6]
interestCoverageTTM	9.55	1.000	7.58	7.58	[3 - 30]
operatingCashFlowPerShareTTM	4.17	2.00	8.61	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.00	2.00	9.00	10.00	[0 - 20]
debtEquityRatioTTM	0.612	-1.500	7.55	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.498	1.000	5.04	5.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.250	1.000	7.01	7.01	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.383	1.000	8.99	8.99	[0.2 - 2]
assetTurnoverTTM	0.666	0.800	8.89	7.11	[0.5 - 2]
Total Score				12.60

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	19.53	1.000	8.13	0	[1 - 100]
returnOnEquityTTM	0.212	2.50	9.20	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.00	2.00	9.33	10.00	[0 - 30]
dividendYielPercentageTTM	1.391	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	4.17	2.00	8.61	10.00	[0 - 30]
payoutRatioTTM	0.258	1.500	7.42	-7.42	[0 - 1]
pegRatioTTM	0.432	1.500	-0.455	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.162	1.000	8.45	0	[0.1 - 0.5]
Total Score				6.59

CSL Limited

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.